Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.53)
# 856
Out of 4,876 analysts
140
Total ratings
51.47%
Success rate
3.47%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $600 → $400 | $302.62 | +32.18% | 16 | May 14, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $239.90 | +29.22% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $330.00 | +13.64% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $8.05 | +49.07% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $53.57 | +58.67% | 17 | Dec 13, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $29.09 | +27.19% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $377.66 | +5.92% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $153.79 | +9.24% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $114.87 | +26.23% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $12.85 | +211.28% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.48 | +43.68% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $9.50 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $555.88 | +16.93% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $98.03 | +47.91% | 10 | Oct 28, 2022 |
UnitedHealth Group
May 14, 2025
Maintains: Outperform
Price Target: $600 → $400
Current: $302.62
Upside: +32.18%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $239.90
Upside: +29.22%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $330.00
Upside: +13.64%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $8.05
Upside: +49.07%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $53.57
Upside: +58.67%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $29.09
Upside: +27.19%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $377.66
Upside: +5.92%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $153.79
Upside: +9.24%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $114.87
Upside: +26.23%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $12.85
Upside: +211.28%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.48
Upside: +43.68%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $9.50
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $555.88
Upside: +16.93%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $98.03
Upside: +47.91%